Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
Eli Lilly and Company
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Actuate Therapeutics Inc.
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
GlaxoSmithKline
Brigham and Women's Hospital
Wake Forest University Health Sciences
Pfizer
Tomsk National Research Medical Center of the Russian Academy of Sciences
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
University of California, Davis
Replimune Inc.
Dana-Farber Cancer Institute
Carevive Systems, Inc.
University of Pennsylvania
Duke University
AstraZeneca
Poseida Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Loma Linda University
AstraZeneca
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
University of Washington
University Health Network, Toronto
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
Brigham and Women's Hospital
Seagen Inc.
Dokuz Eylul University
Incyte Corporation
Varian, a Siemens Healthineers Company
Complement Theory Inc.
Kaiser Permanente
City of Hope Medical Center
AstraZeneca
Memorial Sloan Kettering Cancer Center
SystImmune Inc.
M.D. Anderson Cancer Center
Pfizer